Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients

Abstract Background In the study on hand, we investigated the effect of IL-6 (−174 G/C; rs 1800795) and TGF-β1 (+915G/C; rs 1800471) gene polymorphisms on the susceptibility to Ovarian Cancer and their effect on plasma levels. IL-6 (−174 G/C) SNP was analyzed using mutagenically separated polymerase...

Full description

Bibliographic Details
Main Authors: Zainab M. Almolakab, Khalid A. El-Nesr, Ehab Hassanin Mohamad Hassanin, Rasha Elkaffas, Ahmed Nabil
Format: Article
Language:English
Published: SpringerOpen 2022-03-01
Series:Beni-Suef University Journal of Basic and Applied Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43088-022-00211-5
_version_ 1818914171638513664
author Zainab M. Almolakab
Khalid A. El-Nesr
Ehab Hassanin Mohamad Hassanin
Rasha Elkaffas
Ahmed Nabil
author_facet Zainab M. Almolakab
Khalid A. El-Nesr
Ehab Hassanin Mohamad Hassanin
Rasha Elkaffas
Ahmed Nabil
author_sort Zainab M. Almolakab
collection DOAJ
description Abstract Background In the study on hand, we investigated the effect of IL-6 (−174 G/C; rs 1800795) and TGF-β1 (+915G/C; rs 1800471) gene polymorphisms on the susceptibility to Ovarian Cancer and their effect on plasma levels. IL-6 (−174 G/C) SNP was analyzed using mutagenically separated polymerase chain reaction (MS-PCR) while TGF-β1 +915G/C (codon 25) SNP was investigated by the sequence-specific primer polymerase chain reaction (SSP-PCR). An enzyme-linked immunosorbent assay (ELISA) was used to quantify IL-6 and TGF-β1 plasma levels in 48 ovarian cancer patients and 48 normal controls. Results Regarding IL 6 (−174 G/C), a significant increase in CC and GC+CC genotypes parallel with the C allele was considered as risk factors for ovarian cancer; on the other hand, the G allele was considered as a protective factor for ovarian cancer. TGF-β1 (+915G/C) investigations showed a significant elevation in GC and GC+CC genotypes which can be considered as a risk factor for ovarian cancer. Plasma IL-6 and TGF-β1 were higher in ovarian cancer patients compared with controls. No specific genotype or allele could be responsible for the elevation of TGF-β1 in ovarian cancer patients’ plasma, while the highest significant value for IL6 in subjects carrying GG and CC genotypes in comparison with GC genotype. Conclusions This study supports an association of IL6 (−174G/C) and TGF-β1 (+915G/C) gene polymorphisms with the susceptibility to ovarian cancer.
first_indexed 2024-12-19T23:42:09Z
format Article
id doaj.art-24be2dc97d6f4d2b97926efaedf011c8
institution Directory Open Access Journal
issn 2314-8543
language English
last_indexed 2024-12-19T23:42:09Z
publishDate 2022-03-01
publisher SpringerOpen
record_format Article
series Beni-Suef University Journal of Basic and Applied Sciences
spelling doaj.art-24be2dc97d6f4d2b97926efaedf011c82022-12-21T20:01:23ZengSpringerOpenBeni-Suef University Journal of Basic and Applied Sciences2314-85432022-03-0111111910.1186/s43088-022-00211-5Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patientsZainab M. Almolakab0Khalid A. El-Nesr1Ehab Hassanin Mohamad Hassanin2Rasha Elkaffas3Ahmed Nabil4Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef UniversityPathology Department, Faculty of Veterinary Medicine, Beni-Suef UniversityObstetrics and Gynecology Department, Faculty of Medicine, Al-Azhar UniversityChemical Pathology Department, Faculty of Medicine, Cairo UniversityBiotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef UniversityAbstract Background In the study on hand, we investigated the effect of IL-6 (−174 G/C; rs 1800795) and TGF-β1 (+915G/C; rs 1800471) gene polymorphisms on the susceptibility to Ovarian Cancer and their effect on plasma levels. IL-6 (−174 G/C) SNP was analyzed using mutagenically separated polymerase chain reaction (MS-PCR) while TGF-β1 +915G/C (codon 25) SNP was investigated by the sequence-specific primer polymerase chain reaction (SSP-PCR). An enzyme-linked immunosorbent assay (ELISA) was used to quantify IL-6 and TGF-β1 plasma levels in 48 ovarian cancer patients and 48 normal controls. Results Regarding IL 6 (−174 G/C), a significant increase in CC and GC+CC genotypes parallel with the C allele was considered as risk factors for ovarian cancer; on the other hand, the G allele was considered as a protective factor for ovarian cancer. TGF-β1 (+915G/C) investigations showed a significant elevation in GC and GC+CC genotypes which can be considered as a risk factor for ovarian cancer. Plasma IL-6 and TGF-β1 were higher in ovarian cancer patients compared with controls. No specific genotype or allele could be responsible for the elevation of TGF-β1 in ovarian cancer patients’ plasma, while the highest significant value for IL6 in subjects carrying GG and CC genotypes in comparison with GC genotype. Conclusions This study supports an association of IL6 (−174G/C) and TGF-β1 (+915G/C) gene polymorphisms with the susceptibility to ovarian cancer.https://doi.org/10.1186/s43088-022-00211-5CytokineIL-6Ovarian cancerPolymorphismTGF-β1
spellingShingle Zainab M. Almolakab
Khalid A. El-Nesr
Ehab Hassanin Mohamad Hassanin
Rasha Elkaffas
Ahmed Nabil
Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
Beni-Suef University Journal of Basic and Applied Sciences
Cytokine
IL-6
Ovarian cancer
Polymorphism
TGF-β1
title Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
title_full Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
title_fullStr Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
title_full_unstemmed Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
title_short Gene polymorphisms of Interleukin 6 (−174 G/C) and transforming growth factor β-1(+915 G/C) in ovarian cancer patients
title_sort gene polymorphisms of interleukin 6 174 g c and transforming growth factor β 1 915 g c in ovarian cancer patients
topic Cytokine
IL-6
Ovarian cancer
Polymorphism
TGF-β1
url https://doi.org/10.1186/s43088-022-00211-5
work_keys_str_mv AT zainabmalmolakab genepolymorphismsofinterleukin6174gcandtransforminggrowthfactorb1915gcinovariancancerpatients
AT khalidaelnesr genepolymorphismsofinterleukin6174gcandtransforminggrowthfactorb1915gcinovariancancerpatients
AT ehabhassaninmohamadhassanin genepolymorphismsofinterleukin6174gcandtransforminggrowthfactorb1915gcinovariancancerpatients
AT rashaelkaffas genepolymorphismsofinterleukin6174gcandtransforminggrowthfactorb1915gcinovariancancerpatients
AT ahmednabil genepolymorphismsofinterleukin6174gcandtransforminggrowthfactorb1915gcinovariancancerpatients